Skip to content

Alpha Cognition ACOG Additional Paid-In Capital

Additional Paid-In Capital at other companies

Biogen logo
BiogenBIIB
$896.7M+42.4%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$420.88M+29.5%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$3.06B+3.7%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$608.43M+14.6%
uniQure logo
uniQureQURE
$1.59B+26.2%
Denali Therapeutics Inc. logo
Denali Therapeutics Inc.DNLI
$3.1B+11.3%

Other financials

Income statement

See full
Revenue$3.5M+20.7%
Gross profit$3.3M+12.7%
Operating income-$8.1M-138%
Net income-$6.5M-276%
EPS (diluted)-$0.32-191%

Balance sheet

See full
Cash & equivalents$54.3M+100,638%
Total equity$57.5M+49.2%
Total assets$69.2M+42.5%

Cash flow

See full
Operating cash flow-$11.8M-477%
CapEx$1.3K-97.9%
Free cash flow-$11.8M-460%

Valuation

See full
Market cap$157.21M+6.6%
P/S14.5×

Profitability

See full
Gross margin89.3%
Operating margin-250.1%
Net margin-232.2%
FCF margin-280.5%

Returns & leverage

See full
Return on equity-52.4%-5.3pp
Current ratio12.6×-4.5×

Where this comes from

Reported directly by Alpha Cognition in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: Alpha Cognition’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alpha Cognition's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alpha Cognition's additional paid-in capital?
Alpha Cognition (ACOG) reported additional paid-in capital of $27.19M in Q1 2026.
How has Alpha Cognition's additional paid-in capital changed year-over-year?
Alpha Cognition's additional paid-in capital increased by 35.4% year-over-year, from $20.08M to $27.19M.
What is the long-term trend for Alpha Cognition's additional paid-in capital?
Over 2 years (2023 to 2025), Alpha Cognition's additional paid-in capital has grown at a 22.3% compound annual growth rate (CAGR), from $17.29M to $25.85M.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.